• depression

    New Research from the CWMH: History of Depression and Anxiety Predict Lower Quality of Life in Midlife Women

    The National Comorbidity Survey estimates that by the time women reach midlife, approximately 23% have experienced at least one episode of major depression and 30% have been diagnosed with an anxiety disorder.  Depression and anxiety disorders are each associated with impaired functioning and lower quality of life (QOL).  There is also some data to suggest that, even after a depressive episode resolves, those with a history of a affective illness have a lower quality of life than those without histories of depression, with impairment in social and interpersonal functioning.

    Infertility Increases Risk of Serious Psychiatric Illness

    Multiple small studies have demonstrated a link between infertility and psychological distress, reporting high rates of anxiety and depressive symptoms among women with infertility.  These studies have evaluated psychiatric symptoms or psychological distress; however, less is known about the prevalence of more significant psychiatric disorders in this population.  

    Measuring the Effects of Antidepressants versus Untreated Depression on Pregnancy Outcomes

    Multiple studies have demonstrated an increased risk of poor neonatal adaptation associated with exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants in late pregnancy.  Results in the literature consistently indicate that about 25%-30% of infants exposed to SSRIs late in pregnancy manifest symptoms of poor neonatal adaption, including jitteriness, restlessness, increased muscle tone, rapid breathing.  These symptoms are transient, resolving spontaneously with no specific medical intervention.

    A Simple Educational Intervention Reduces the Risk of Postpartum Intervention

    While postpartum depression can affect all women, there are certain populations which appear to be at particularly high risk, including women of lower socioeconomic status.  These women have limited access to resources and have multiple stressors including housing problems, financial strain, and being a single parent.  Researchers recently piloted an intervention randomized controlled trial involving 540 participants at an inner-city hospital in East Harlem, New York.  The primary goal of this psychoeducational intervention was to reduce the risk of postpartum depression among black and Latina mothers.

    Infertility Treatment is Stressful: But Does Stress Affect the Chances of Getting Pregnant?

    It is common for women experiencing infertility and undergoing fertility treatment to experience significant emotional distress.  Many women, reasoning that their emotional health influences their physical functioning, worry that the stress and anxiety they experience in this context may hinder their ability to become pregnant.

    In Brief: Menopausal Symptoms Usually Go Untreated

    In this study, half of women aged 45 to 60 years reported experiencing menopausal symptoms. 69% of these women reported that their symptoms have negatively  affected their lives. Among the women who endorsed menopausal symptoms, 72% had not received any treatment for their symptoms and 77% reported that they had not discussed treatment options with their healthcare providers.

    Will PMDD Have a New Home in the DSM-V?

    The American Psychiatric Association is now considering the possibility of including premenstrual dysphoric disorder (PMDD) in the DSM-V as a new category, rather than listing a set of criteria for PMDD in the appendix (as in DSM-IV).  The diagnostic criteria remain relatively unchanged.  Many feel that the Inclusion of PMDD as a distinct diagnostic category will lead to greater legitimacy for the disorder and will encourage the growth of evidence-based research in this area.

    By |2015-08-12T15:17:11-04:00June 1st, 2012|PMS and PMDD|0 Comments

    New Research from the CWMH: Progestins Do Not Negatively Affect Mood in Peri- and Postmenopausal Women

    More than half of all women initiating treatment with hormone therapy will stop within the first year of treatment, most often because of side effects.  Mood disturbance is a relatively common side effect that occurs with hormone therapy, and previous studies have suggested that progestins in the combined hormone preparations are responsible for these negative mood effects.

    Go to Top